• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of the molecular process in the development of osteosarcomas by in vitro transformation.

Research Project

Project/Area Number 08457388
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

TOGUCHIDA Junya  Kyoto University, Research Center for Biomedical Engineering, Assistant Professor, 生体医療工学研究センター, 助教授 (40273502)

Co-Investigator(Kenkyū-buntansha) SASAKI Masao  Kyoto University, Radiation Biology Center, Professor, 放射線生物研究センター, 教授 (20013857)
NAKAMURA Takashi  Kyoto University, Faculty of Medicine, Department of Orthopaedic Surgery, Profes, 医学研究科, 教授 (10201675)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥7,600,000 (Direct Cost: ¥7,600,000)
Fiscal Year 1997: ¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 1996: ¥4,200,000 (Direct Cost: ¥4,200,000)
Keywordsosteosarcoma / p53 gene / RB gene / transformation / differential display / Rb遺伝子 / 骨芽細胞
Research Abstract

1.Establishment of osteoblast-like cell line, MMC2, from p53 deficient mice.
Osteoblast-like cell line was established from calvarie of p53 knock-out mice. MMC2 showed growth immortalized. However, showed anchorage-dependent growth, and contact inhibition. There fore not transformed. MMC2 was found to possess differentiated phenotypes as osteoblasts, such as ALP activity, mRNA expression of type collagen and osteocalcin genes. Also calcified matrix was produced in vitro.
2.Establishment of a transformed cell line by the introduction of HPV16E7 gene into MMC2.
To inactivate the function of RB protein, HPV16E7 gene was introduced into MMC2 cells, and cells were inoculated onto nu/nu mice. A cell line (E7TC) was established from tumor tissue developed in one mouse. E7TC showed deregulated expression of cyclin A2 and thymidine kinase genes, suggesting the increased activity of E2F in this cell line. On the hand, differentiated phenotypes as osteoblasts were lost, and pathological findings of … More tumor produced by E7TC were not compatible with osteosarcoma, rather undifferentiated sarcomas.
3.Establishment of spontaneous transformed cell line (MMC2TC23).
Suncutaneous tumor formation was noticed in one mouse 8 month after the inoculation of MMC2. In vitro cell line was established from this tumor (TC23). TC23 showed several phenotypes as a full transformed cell line like E7TC,but at the same time possessed phenotypes as differentiated osteoblasts. Tumor produced by TC23 showed typical findings as human osteosarcomas. Therefore we have succeed to establish two phenotypically different sarcoma cell lines from MMC2.
4.Isolation of novel genes by differential display method.
Differential display method was used to isolate genes which has changed the expression during the course of full transformation from MMC2 to either E7TC or TC23. So far two novel genes were isolated : one showed increased expression in E7TC,and the other lost expression in E7TC.Full length cDNAs of these two genes are currently under cloning. Less

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Nakayama, Tomitaka: "Fracture healing is a process independent from p53 function." In vivo. 10. 553-558 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nakayama, Tomitaka: "Establishment of osteoblast like cell line,MMC2,from p53 deficient mice." Bone. 21. 313-319 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yamaguchi, Toshikazu.: "Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas." Anticancer Researh. 16. 2009-2010 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kato, Mitsuo V.: "loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma." Cancer Letters. 106. 75-82 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 戸口田 淳 也: "骨肉腫の増殖における癌抑制遺伝子変異の意義" 臨床整形外科. 32. 7-15 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 戸口田 淳 也: "軟部肉腫と癌遺伝子" 病理と臨床. 16. 126-134 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nakayama, Tomitaka: "Fracture healing is a process independent from p53 function." In vivo. 10. 553-558 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nakayama, Tomitaka: "Establishment of osteoblast-like cell line, MMC2, from p53 deficient mice." Bone. 21. 313-319 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Yamaguchi, Toshikazu: "Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcoma" Anticancer Research. 16. 2009-2016 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kato, Mitsuo V.: "Loss of heterozygosity on chromosome 17 and mutations of the p53 gene in retinoblastoma." Cancer Letters. 106. 75-82 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Toguchida, Junya: "Significance of tumor suppressor gene mutations in the development of osteosarcoma." Rinsho Sekei Geka. 32. 7-15 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Toguchida, Junya: "Oncogenes and tumor suppressor genes mutations in soft tissue sarcomas." Pathology and Clinical Medicine. 16. 126-134 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nakayama,Tomitaka: "Fracture nealing is a process independent from p53 function." In vivo. 10. 553-558 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Nakayama,Tomitaka: "Establishment of osteoblast-like cell line,MMC2,from p53 deficient mice." Bone. 21. 313-319 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yamaguchi,Toshikazu.: "Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas." Anticancer Research. 16. 2009-2016 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kato,Mitsuo V.: "Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma." Cancer Letters. 106. 75-82 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] 戸田口 淳也: "骨肉腫の増殖における癌抑制遺伝子変異の意義" 臨床整形外科. 32. 7-15 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 戸田口 淳也: "軟部肉腫と癌遺伝子" 病理と臨床. 16. 126-134 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Yamaguchi,et al.: "Loss of heterozygosity and suppressor gene mutations in chondrosarcomas." Anticancer Res. 16. 2009-2016 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] M.V.Kato,et al.: "Loss of heterozygosity on chromosome 17 and mutations of the p53 gene in retinoblastoma." Cancer Letters. 106. 75-82 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] T.Nakayama,et al.: "Fracture healing is a process independent of p53 function." in vivo. 10. 553-558 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi